Application 103532
- Type
- BLA
- Sponsor
- GENENTECH
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103532 | Pulmozyme | dornase alfa | 351(a) | Rx | 2026-08-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PULMOZYME | DORNASE ALFA | VIAL | 1MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pulmozyme | DORNASE ALFA | Genentech, Inc. | d8c78a7e-ff99-48f3-8952-643ec2ea0f86 | 2025-12-17 | Warnings, Adverse reactions | BLA103532 50242-100 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50242-100 | Pulmozyme | dornase alfa | Genentech, Inc. | BLA | Current |
| 50242-100 | Pulmozyme | dornase alfa | Genentech, Inc. | BLA | Current |
| 50242-100 | Pulmozyme | dornase alfa | Genentech, Inc. | BLA | Current |
| 50242-100 | Pulmozyme | dornase alfa | Genentech, Inc. | BLA | Current |
| 50242-100 | Pulmozyme | dornase alfa | Genentech, Inc. | BLA | Current |
| 50242-100 | Pulmozyme | dornase alfa | Genentech, Inc. | BLA | Current |